SERAPH BIOSCIENCES, INC. — Form D/A
SERAPH BIOSCIENCES, INC. of DETROIT, MI, a company, filed a Form D amendment with the SEC on 2021-08-23. The offering totals $7.2M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-08-23
- Form: D/A
- Accession: 0000905729-21-000173
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.2M
- Amount sold: $7.0M
- Remaining: $178K
- Investors: 29
- Date of first sale: 2018-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-369574
Issuer
- Name: SERAPH BIOSCIENCES, INC.
- CIK: 0001697736
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 1001 WOODWARD AVENUE, DETROIT, MI, 48226
- Phone: 313-759-8009
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Richard Nadeem Creager | Director | Detroit, MI |
| Ahmad Nadeem Ishaque | Director | Detroit, MI |
| Gary Loveman | Director | Detroit, MI |
| Scott Nadeem Merz | Director | Detroit, MI |
| Charles Shanley | Director | Detroit, MI |
| Michael Shields | Director | Detroit, MI |
| Braden Nadeem Robison | Executive Officer | Detroit, MI |
| James Nadeem Shanley | Executive Officer | Detroit, MI |
| James Mault | Director | Golden, CO |
| Charles Shanley | Executive Officer | Detroit, MI |
| Scott Merz | Director | Detroit, MI |
| Paul Glantz | Director | Detroit, MI |
| Gregory Auner | Director | Detroit, MI |
| Gregory Auner | Executive Officer | Detroit, MI |
| Matthew Cullen | Director | Detroit, MI |
| James Shanley | Executive Officer | Detroit, MI |
| Braden Robison | Executive Officer | Detroit, MI |
| MARK TREXLER | Executive Officer | DETROIT, MI |
Other filings by this issuer (3)
More